[{"Assets_0_Q3_USD":173970000.0,"CommonStockSharesOutstanding_0_Q3_shares":71954843.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-57745000.0,"NetIncomeLoss_1_Q3_USD":-22149000.0,"NetIncomeLoss_3_Q3_USD":-66210000.0,"StockholdersEquity_0_Q3_USD":165441000.0,"Ticker":"IOVA","CIK":"1425205","name":"IOVANCE BIOTHERAPEUTICS, INC.","OfficialName":"Iovance Biotherapeutics Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2593277297.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171102"}]